We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Developing Presubmission Policy to Improve Drug Pipeline
FDA Developing Presubmission Policy to Improve Drug Pipeline
April 21, 2006
The FDA will soon implement a new policy formalizing presubmission reviews of drug applications to improve the drug pipeline by cutting down on both regulatory and industry inefficiency, Andrew von Eschenbach, the agency’s acting commissioner, says.